EyePoint Pharmaceuticals資訊中心

EyePoint Pharmaceuticals 分析師評級

Benzinga14:48 (美東)

花旗首次給予EyePoint Pharmaceuticals(EYPT.US)買入評級，目標價33美元

moomoo資訊01/07 06:36 (美東)

JonesTrading維持EyePoint Pharmaceuticals(EYPT.US)買入評級，維持目標價45美元

moomoo資訊01/02 11:32 (美東)

H.C. Wainwright維持EyePoint Pharmaceuticals(EYPT.US)買入評級，維持目標價22美元

moomoo資訊2024/12/05 12:31 (美東)

JonesTrading維持EyePoint Pharmaceuticals(EYPT.US)買入評級，維持目標價45美元

moomoo資訊2024/12/05 11:33 (美東)

eyepoint pharmaceuticals價格目標保持在$22.00/Share，由HC Wainwright & Co。

道瓊斯2024/12/05 06:30 (美東)

eyepoint pharmaceuticals 分析師評級

Benzinga2024/12/05 06:20 (美東)

JonesTrading維持EyePoint Pharmaceuticals(EYPT.US)買入評級，維持目標價45美元

moomoo資訊2024/12/02 17:31 (美東)

貝雅維持EyePoint Pharmaceuticals(EYPT.US)買入評級，下調目標價至33美元

moomoo資訊2024/11/11 07:31 (美東)

JonesTrading維持EyePoint Pharmaceuticals(EYPT.US)買入評級，維持目標價45美元

moomoo資訊2024/11/11 07:31 (美東)

H.C. Wainwright維持EyePoint Pharmaceuticals(EYPT.US)買入評級，下調目標價至22美元

moomoo資訊2024/11/11 07:31 (美東)

eyepoint pharmaceuticals被HC Wainwright和Co維持在買入

道瓊斯2024/11/11 07:24 (美東)

eyepoint pharmaceuticals價格目標從30.00美元降至22.00美元，由HC Wainwright & Co.進行裁減。

道瓊斯2024/11/11 07:24 (美東)

TD Cowen維持EyePoint Pharmaceuticals(EYPT.US)買入評級，下調目標價至20美元

moomoo資訊2024/11/07 12:30 (美東)

eyepoint pharmaceuticals：臨床試驗進展及有望的中期數據推動了買入評級

TipRanks2024/11/07 11:50 (美東)

豐業銀行維持EyePoint Pharmaceuticals(EYPT.US)買入評級，維持目標價18美元

moomoo資訊2024/10/29 07:34 (美東)

eyepoint pharmaceuticals被Chardan Capital維持爲買入

道瓊斯2024/10/29 07:11 (美東)

eyepoint pharmaceuticals 分析師評級

Benzinga2024/10/29 06:59 (美東)

第一資本維持EyePoint Pharmaceuticals(EYPT.US)買入評級，維持目標價35美元

moomoo資訊2024/10/28 11:32 (美東)

JonesTrading首次給予EyePoint Pharmaceuticals(EYPT.US)買入評級，目標價45美元

moomoo資訊2024/10/28 10:32 (美東)